LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 92.98 | 84.90 | 13586 | 7257 | 1.8720 | 1.2053 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 94.68 | 84.90 | 1098 | 7000 | 0.1569 | 0.4950 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 94.68 | 84.90 | 11941 | 7000 | 1.7058 | 1.1750 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 94.68 | 84.90 | 410 | 7000 | 0.0586 | 0.2807 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 94.68 | 84.90 | 13908 | 7000 | 1.9867 | 1.2278 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 2.66 | 84.90 | 438 | 285 | 1.5329 | 1.5526 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 2.66 | 84.90 | 681 | 285 | 2.3833 | 2.2843 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 4.36 | 84.90 | 4 | 322 | 0.0124 | -0.7953 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 4.36 | 84.90 | 582 | 322 | 1.8043 | 1.7171 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 4.36 | 84.90 | 775 | 322 | 2.4026 | 2.1528 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 6.06 | 84.90 | 4 | 365 | 0.0109 | -0.7656 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 6.06 | 84.90 | 659 | 365 | 1.8032 | 1.6462 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 6.06 | 84.90 | 842 | 365 | 2.3040 | 1.9727 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.77 | 84.90 | 4 | 411 | 0.0097 | -0.7387 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.77 | 84.90 | 750 | 411 | 1.8238 | 1.6042 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.77 | 84.90 | 960 | 411 | 2.3344 | 1.9026 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 9.47 | 84.90 | 4 | 447 | 0.0089 | -0.7203 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 9.47 | 84.90 | 787 | 447 | 1.7589 | 1.5311 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 9.47 | 84.90 | 1032 | 447 | 2.3065 | 1.8340 | MN20160318_Q02 | I04 |